BIOMERIEUX (EPA:BIM)

REGULATED PRESS RELEASE

published on 04/07/2025 at 07:01, 1 year ago

bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship
bioMérieux obtains CE-marking for LUMED™ APSS™, a cutting-edge software solution to aid medical decision-making in Antimicrobial Stewardship. LUMED™ APSS™ enhances antimicrobial stewardship programs by offering real-time alerts, data-driven decisions, and tailored support for medical teams

BioMérieux Clinical Decision Support System Antimicrobial Stewardship CE-marking LUMED APSS
BRIEF

published on 04/02/2025 at 14:18, 1 year 1 month ago

Evolution of Capital and Voting Rights at bioMérieux

Share Capital Voting Rights BioMérieux Actions Financial Transparency
BRIEF

published on 03/24/2025 at 09:35, 1 year 1 month ago

BioMérieux Files 2024 Universal Registration Document

Financial Performance BioMérieux Investor Relations Annual Report 2024 Results
BRIEF

published on 03/24/2025 at 09:33, 1 year 1 month ago

Publication of the bioMérieux Universal Registration Document

Investors BioMérieux AMF Registration Document 2024 Financial Report
REGULATED PRESS RELEASE

published on 03/24/2025 at 09:30, 1 year 1 month ago

Release of the Universal Registration Document including the Annual Financial Report as of December 31, 2024
bioMérieux releases the Universal Registration Document, including the Annual Financial Report as of December 31, 2024, available for public access

BioMérieux Investor Relations Financial Report Universal Registration Document Public Access
BRIEF

published on 03/18/2025 at 07:06, 1 year 1 month ago

BioMérieux's VITEK® COMPACT PRO Gains FDA Clearance

BioMérieux Antimicrobial Resistance FDA Clearance Diagnostics VITEK® COMPACT PRO
REGULATED PRESS RELEASE

published on 03/18/2025 at 07:01, 1 year 1 month ago

bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance
bioMérieux receives FDA 510(k) Clearance for VITEK® COMPACT PRO, a new ID/AST system to combat antimicrobial resistance. The system benefits clinical and industrial laboratories for faster and accurate diagnostics

BioMérieux Antimicrobial Resistance FDA Clearance VITEK COMPACT PRO ID/AST System
BRIEF

published on 03/14/2025 at 08:40, 1 year 1 month ago

2025 General Meeting: Preparatory Documents Available from bioMérieux

Shareholders BioMérieux General Meeting Preparatory Documents Legal Information
REGULATED PRESS RELEASE

published on 03/07/2025 at 07:01, 1 year 1 month ago

bioMérieux – 2024 Financial Results
BRIEF

published on 03/04/2025 at 14:41, 1 year 2 months ago

Statement on the share capital and voting rights of bioMérieux

Share Capital Voting Rights BioMérieux Actions February 2025

Published on 05/06/2026 at 02:17, 4 hours 48 minutes ago

Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 5 hours 5 minutes ago

Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 5 hours 5 minutes ago

Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 5 hours 35 minutes ago

Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 5 hours 45 minutes ago

Empress Grants Stock Options and Equity Incentives

View all ACCESSWIRE

Published on 05/06/2026 at 06:55, 9 minutes ago

Fresenius invests in Avelios Medical and further expands its strategic partnership with SAP
Published on 05/06/2026 at 06:47, 17 minutes ago

3-month result 2026: Basler AG starts fiscal year 2026 with very strong growth in incoming orders, revenues, and earnings
Published on 05/06/2026 at 06:45, 20 minutes ago

#FutureFresenius: REJUVENATE in action – Excellent start to the year - demonstrating continued strength and resilient performance; Guidance reconfirmed
Published on 05/06/2026 at 06:30, 35 minutes ago

HENSOLDT starts financial year 2026 with record order intake and rising profitability
Published on 05/06/2026 at 06:30, 35 minutes ago

Redcare Pharmacy starts 2026 with a strong topline performance and a 58% increase of adj. EBITDA.

View all EQS

Published on 05/05/2026 at 19:00, 12 hours 5 minutes ago

Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:40, 12 hours 25 minutes ago

Share Buyback program
Published on 05/05/2026 at 18:03, 13 hours 1 minute ago

Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
Published on 05/05/2026 at 17:56, 13 hours 9 minutes ago

NRJ GROUP - Financial Information Q1 2026
Published on 05/05/2026 at 17:53, 13 hours 11 minutes ago

TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026

View all LES ECHOS COMFI WIRE

News